However, there are inconsistent results on the effects of GLP-1 receptor agonists on the changes in body composition in obesity and diabetes (7), and there is a lack of clinical studies to observe effects of GLP-1 receptor agonists on abdominal fat distribution. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.